Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

dard of care."

The Phase 3 study was designed to compare the safety and efficacy of motavizumab with that of Synagis, which was first launched by MedImmune in 1998, in reducing serious RSV disease in high-risk infants in the inpatient and outpatient settings. As defined in the study, infants who are at high risk for RSV include those who were born at 35 weeks gestation or less as well as those who have chronic lung disease (CLD) due to being born prematurely. The primary endpoint was to assess the incidence of RSV hospitalizations with motavizumab compared to Synagis. Motavizumab met the primary endpoint, demonstrating non-inferiority to Synagis with 26 percent fewer RSV hospitalizations in motavizumab-treated infants. The overall RSV attack rate was low in both treatment groups: 1.4 percent for infants who received motavizumab, compared with 1.9 percent for those who received Synagis [RR: 0.740, 95 percent CI: (0.503, 1.083)]. The p-value for non-inferiority was p<0.01, demonstrating a significant finding.

Analysis of the data also showed that motavizumab reduced the incidence of RSV-specific medically attended outpatient LRIs (the study's RSV-related secondary endpoint) by approximately 50 percent compared with Synagis. The overall RSV-specific medically attended LRI rate was 2.0 percent for infants who received motavizumab compared with 3.9 percent for those who received Synagis (p<0.01). There were no significant differences in other non-RSV- specific endpoints.

"I am very pleased with the study results for motavizumab," said Xavier Carbonell, M.D., Ph.D., lead study author, chairman of neonatology, Barcelona Hospital Clinic, and vice president, Spanish Neonatal Society. "As a practicing neonatologist, I look forward to the potential to use this next- generation antibody to help reduce RSV-related hospitalizations and LRIs in the outpatient setting."

Data from this trial demonstrate that both study drugs were well tolerated. The incid
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:9/1/2015)... Alpha Imaging LLC , a leading distributor of advanced medical imaging ... they have been awarded exclusive rights to represent the complete Shimadzu ... territory supplements Alpha Imaging,s existing Shimadzu sales and service responsibilities with ... Indiana , Pennsylvania , ... West Virginia , Delaware and ...
(Date:9/1/2015)... -- Results from an interim analysis of the Phase ... idarucizumab enabled emergency surgery to be initiated rapidly ... (Pradaxa ® dabigatran etexilate mesylate). The specific and ... enabled patients to be urgently brought to necessary ... between administration of idarucizumab and start of procedure. ...
(Date:9/1/2015)... Belgium , Sept. 1, 2015 VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... Executive Officer, Cameron Reynolds , is scheduled to attend ... is being held September 9-10, 2015 in Boston, ... on September 10. Wells Fargo Securities Research ...
Breaking Medicine Technology:Alpha Imaging Expands Shimadzu Territory 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4
... Oct. 11 ECRI Institute® ( www.ecri.org ), an ... improving patient care, is pleased to announce Kaiser Permanente ... health plan,  as the winner of the 5th annual ... health technology management. The Health Devices Achievement Award ...
... N.C., Oct. 11 Talecris Biotherapeutics Holdings Corp. (Nasdaq: ... release before the market opens on October 28, 2010. Due ... be hosting a conference call to discuss its third quarter ... Inspiration. Dedication. Innovation. Talecris Biotherapeutics is ...
Cached Medicine Technology:ECRI Institute Names Kaiser Permanente Winner of 5th Annual Health Devices Achievement Award 2ECRI Institute Names Kaiser Permanente Winner of 5th Annual Health Devices Achievement Award 3
(Date:9/1/2015)... ... ... The Jerry Segal Classic to benefit the patients of Magee Rehabilitation Hospital returns ... Hill, PA. Over the past 26 years, the Classic, organized by the Friends of ... support patients and their families during their time at Magee Rehabilitation Hospital. , ...
(Date:9/1/2015)... Freeport, ME (PRWEB) , ... September 01, 2015 , ... ... a large, new study that followed men and women for 19 years and found ... those who did not take multivitamins. , The report is part of the September ...
(Date:9/1/2015)... ... September 01, 2015 , ... Agriculture innovation, urban farming, local ... the topics to be discussed at Seedstock’s 4th Annual Sustainable Agriculture Conference : ... San Diego. , In addition to keynotes Pierre Sleiman, founder and CEO of ...
(Date:9/1/2015)... ... September 01, 2015 , ... Mercy Health (formerly Catholic ... the 10th of its monthly Mercy Health: Helping You Be Well videos to prostate ... seven men. , In a concise video on Mercy Health’s YouTube channel, Mercy ...
(Date:9/1/2015)... ... September 01, 2015 , ... Situations requiring fast, easy-to-understand ... the most convenient time for everyone involved. These occasions highlight the value of ... Translation Services has real people available to handle any translation assignment at ...
Breaking Medicine News(10 mins):Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3
... Provides Holistic Process Support for Oversight of Global Clinical ... 22 Sparta Systems, Inc., ... in enterprise quality and compliance management, today announced the ... end-to-end system that streamlines the oversight of business-critical clinical ...
... Americans see the nation,s health-care system as at or near ... according to new research released today by Public Agenda and ... Thinking about Coping with the Cost of Health Care, ... citizens in deliberative forums held in 40 states and the ...
... HIV Burden Clustered in Only 20% of Counties , ... National Minority Quality Forum today launched a groundbreaking HIV/AIDS Atlas ... epidemic in communities across the United States. The Atlas makes ... for the first time, painting a comprehensive picture of the ...
... Forum Launches First U.S. HIV/AIDS Atlas , , WASHINGTON, ... a groundbreaking HIV/AIDS Atlas ( http://www.MapHIV.org ... communities across the United States. The Atlas makes information ... the first time, painting a comprehensive picture of the varying ...
... First U.S. HIV/AIDS Atlas , , WASHINGTON, June 22 ... HIV/AIDS Atlas ( http://www.MapHIV.org ) that ... the United States. The Atlas makes information on HIV/AIDS ... time, painting a comprehensive picture of the varying intensity of ...
... National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas , ... Forum today launched a groundbreaking HIV/AIDS Atlas ( ... HIV/AIDS epidemic in communities across the United States. The ... single location for the first time, painting a comprehensive picture ...
Cached Medicine News:Health News:Sparta Systems Unveils TrackWise(R) Clinical Quality Management Solution 2Health News:Sparta Systems Unveils TrackWise(R) Clinical Quality Management Solution 3Health News:Public Ready for Changes to Health-Care System But Unclear About Necessary Trade-Offs, Citizen Forums Suggest 2Health News:Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas 2Health News:Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas 3Health News:MapHIV.org Shows Nearly 24% of Counties in New Jersey Seriously Impacted by HIV and AIDS 2Health News:MapHIV.org Shows Nearly 24% of Counties in New Jersey Seriously Impacted by HIV and AIDS 3Health News:MapHIV.org Shows Eight Counties in Virginia Seriously Impacted by AIDS 2Health News:MapHIV.org Shows Eight Counties in Virginia Seriously Impacted by AIDS 3Health News:MapHIV.org Shows 18% of Georgia's Counties are Seriously Impacted by HIV 2Health News:MapHIV.org Shows 18% of Georgia's Counties are Seriously Impacted by HIV 3
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro...
... preservative free lubricating and rewetting ... eyes while you're wearing soft ... free formula is ideal for ... to preservatives and for frequent ...
Saline Solution to rinse and store soft contact lenses and for heat disinfection....
Sensitive Eyes Plus Saline Solution to rinse soft contact lenses The unique, gentle, pH-balanced formula contains potassium, an ingredient found in tears....
Medicine Products: